460 Totten Pond Road
56 articles with Glytec LLC
Glytec and Roche Announce Strategic Partnership to Bring Digital Health Innovation in Glycemic Decision Support to the Hospital Bedside
Glytec, the only provider of cloud-based insulin management software across the continuum of care, announced a strategic partnership with Roche Diagnostics USA, a division of the world’s largest biotech company and a global pioneer in pharmaceuticals and diagnostics.
Healthcare Industry Leaders Unite Around Patient Safety at Glytec’s Inaugural Conference on Glycemic Innovation and Collaboration
Glytec, the only provider of cloud-based insulin management software across the continuum of care, today revealed details about its inaugural conference on glycemic innovation and collaboration, “Time to Target: Uniting Around Patient Safety.”
7/16/2021Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
6/25/2021Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Glytec today announced the appointment of Nausheen Moulana as Chief Technology Officer.
Metro Health – University of Michigan Health Reduces Glycemic Events with Glytec’s eGlycemic Management System
University of Michigan Health Affiliate Halves Hypoglycemic Events and Reduces Hyperglycemia by 40% with Personalized Insulin Dosing Software
Pandemic Highlights Critical Role of Technology-Driven Glycemic Management as Glytec Propels Customer Base Past 300 Healthcare Facilities
Nationally-Recognized Research and the Imperative for Health Systems to Free Beds and Improve Outcomes More Quickly Fuel Insulin Dosing Technology Company’s Growth
Glytec’s Glucommander Software Combined with Continuous Glucose Monitoring Enables Patients with Diabetes to Improve Time in Range by More than 25% in Only Four Weeks
First study to utilize CGM data with FDA-cleared software to support basal-bolus insulin injection regimens suggests significantly improved outcomes for patients while optimizing clinical resources WALTHAM, Mass.--( BUSINESS WIRE )-- Glytec , the only provider of insulin management software across the continuum of care, today published the first proof-of-concept study that combines data from continuous glucose monitoring (CGM) systems with FDA-clear
Healthcare Providers Share Results of Computer-Guided Insulin Dosing through Glytec During Diabetes Technology Society’s Virtual Hospital Meeting
AdventHealth and CHI Franciscan Lead Three-Part Session with Data on Quality and Cost Improvements Achieved Through Electronic Glucose Management WALTHAM, Mass.--( BUSINESS WIRE )-- Glytec , the only provider of insulin management software across the continuum of care, announced today that AdventHealth and CHI Franciscan will lead a three-part session titled, “Computer-Guided Insulin Dosing” at the 2020 Diabetes Technology Society (DTS) Virtual
As One-Third of Patients Experience Increased Hospital Stays, Readmissions and Costs Due to Hypoglycemia and Hyperglycemia, eGMS Improves Outcomes and Quality of Care
Results of a nationwide survey indicate most hospitals do not employ best practices in glucose control, which leads to increased safety risks, higher readmission rates and significantly greater costs.
The not-for-profit community medical center is partnering with Glytec to facilitate standardization of best practices in diabetes therapy management.
New product will be the market’s first and only to enable optimization of ALL diabetes medications, insulin and non-insulin alike.
The digital therapeutics pioneer is expanding its intellectual property footprint beyond the U.S., gaining worldwide protections for its proprietary diabetes therapy management solutions.
Glytec Awarded Patent Allowance for Virtual Insulin Titration in Concert with CGM, Smart Pens and Other Diabetes Technologies
The company’s growing intellectual property portfolio attests to its leadership position in diabetes medication optimization in an era of data-driven care.
The May 30, 2019 webinar will explore the keys to augmenting traditional brick-and-mortar care with virtual care for people with diabetes.
The Wyoming, Michigan-based healthcare organization will partner with Glytec to provide patients an integrated model of technology-enabled glycemic management
The company is expanding its software-as-a-medical-device platform to support the optimization of ALL diabetes medications.
Glytec, the pioneer of digital therapeutics and leader in insulin optimization, welcomes Paula LeClair as Executive Director and General Manager, Outpatient. I
Glytec to Host Webinar in Partnership with American Hospital Association: Improving the Quality and Cost of Diabetes Care
The December 13, 2018 webinar is open to hospital and health system personnel nationwide and will feature Dr. Richard E. Pratley of Florida Hospital System and Dr. Steven V. Edelman of UC San Diego Health.